Comparison
NMN vs Magnesium Glycinate
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Magnesium Glycinate
Chelated magnesium with high bioavailability and minimal laxative effect. The de facto sleep magnesium.
| Field | NMN | Magnesium Glycinate |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 200–400mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEB |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 1200 |
The comparison in plain English
Auto-generated from dataNMN and Magnesium Glycinate are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Magnesium Glycinate Chelated magnesium with high bioavailability and minimal laxative effect.
Bottom line
NMN (evidence B, safety 5/5) matches the evidence base of Magnesium Glycinate (evidence B, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Magnesium Glycinate if
Magnesium Glycinate is the better fit when your goal aligns with its mechanism (Magnesium chelated with glycine for high bioavailability and minimal laxative effect) and the dose range (200–400mg) suits your protocol. Half-life is —h.